{
    "2019-06-28": [
        [
            {
                "time": "",
                "original_text": "智飞生物深度报告:产品及研发管线存在显著预期差,疫苗绝对龙头长期市值有望突破2000亿",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "产品",
                        "研发管线",
                        "预期差",
                        "疫苗",
                        "绝对龙头",
                        "长期市值",
                        "2000亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}